XPAR
LTA
Market cap924mUSD
Oct 09, Last price
22.50EUR
1D
-0.88%
1Q
-3.02%
Jan 2017
76.19%
IPO
101.85%
Name
Altamir
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Altamir SCA, formerly known as Altamir Amboise, operates as a private equity firm that engages in both direct equity investments and fund-of-fund strategies, primarily targeting small and medium-sized companies. For its direct investment activities, the firm focuses on middle-market opportunities, encompassing buyout and growth capital financing. A particular area of interest is the acquisition of underdeveloped divisions within larger corporations. When investing in other funds, Altamir gravitates towards private equity vehicles dedicated to growth capital and leveraged buyout transactions. The firm's sectorial interests are diverse, spanning healthcare, technology, media, and telecommunications (TMT), digital enterprises, various service industries, and retail and distribution. Within healthcare, it specifically seeks high-growth potential in areas such as health services (e.g., hospitalization, home care, medical analysis), medical devices, niche pharmaceutical laboratories, and related sectors like dermo-cosmetics, galenic development, and data/service providers for health organizations. Broader retail, consumer, business, and financial services also fall within its purview. Geographically, Altamir seeks unlisted companies primarily across Europe, including Belgium, France, Luxembourg, Switzerland, Monaco, Italy, the Netherlands, Germany, and French-speaking Europe, alongside the United States, Canada, and key emerging markets like China, India, and Brazil. For small and mid-cap companies, its preference lies in Continental Europe, with a strong focus on France, Italy, and the Benelux region. For larger enterprises, its investment reach extends to Europe, North America, and emerging economies such as China, India, and Brazil. Altamir typically targets small and mid-cap companies with an enterprise value ranging from €50 million ($55.36 million) to €500 million ($553.6 million). For larger companies, the enterprise value for investment falls between €500 million ($553.60 million) and €3,000 million ($3,321.62 million). When investing in funds, the firm aims for a majority ownership stake or a leading shareholder position. Altamir aligns its investment and divestment processes with the private equity funds of Apax Partners France and Amboise Investissement under identical conditions, and also directly invests in funds managed or advised by Apax Partners France and Apax Partners LLC. The firm's objective is to exit its investments within a five-year timeframe, and all capital deployment is made from its own balance sheet. Altamir SCA was established in 1995 and is based in Paris, France.
Related entities
Subsidiaries
ALTASTORY
Key people
Jean-Hugues Loyez
Chairman of the Supervisory Board · since 2015
Eric Sabia
Financial Director · since 2016
Patrick de Giovanni
Manager
Jean Estin
Non-Executive Independent Member of the Supervisory Board · since 2018
Marleen Groen
Non-Executive Independent Member of the Supervisory Board · since 2014
Non-Executive Independent Director of the Supervisory Board · since 2014
Headquarters & legal address
61 RUE DES BELLES FEUILLES
PARIS 75016
FR
PARIS 75016
FR
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||